Brazilian workshop model to train investigators in chronic graft-versus-host disease clinical trials according to the 2005-2006 National Institutes of Health recommendations
暂无分享,去创建一个
L. Bouzas | M. Flowers | A. Ferrari | A. Vigorito | M. E. Corrêa | C. V. de Souza | E. Nunes | M. Mauad | M. Silva | R. Tavares | V. Funke | Maria Cláudia Rodrigues | A. Paixão | T. Martins | É. Pallottino
[1] B. Kurland,et al. Validation of measurement scales in ocular graft-versus-host disease. , 2012, Ophthalmology.
[2] Li Li,et al. A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] B. Storer,et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. , 2011, Blood.
[4] Sophia Cornbluth Szarfarc. Políticas públicas para o controle da anemia ferropriva , 2010 .
[5] Afonso Celso Vigorito,et al. Diretrizes para o diagnóstico, classificação, profilaxia e tratamento da doença enxerto contra hospedeiro crônica , 2010 .
[6] H. Greinix,et al. A single-center pilot validation study of a new chronic GVHD skin scoring system. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] C. Dinarello,et al. 35: Histone deacetylase inhibitors induce indoleamine 2, 3-dioxygenase and modulate dendritic cell functions , 2007 .
[8] M. Turner,et al. Cutaneous manifestations of chronic graft-versus-host disease. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[9] S. Hirschfeld,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] Steven Hirschfeld,et al. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report , 2006 .
[11] L. Luznik,et al. Host Langerhans cells (LCs) can be therapeutically manipulated In vivo with imiquimod (TLR7 agonist) to augment DLI-mediated GVH and GVL reactivity , 2006 .
[12] An Liu,et al. Targeted total marrow irradiation using 3D image guided tomographic intensity modulated radiation therapy: An alternative to standard TBI , 2006 .
[13] A. Nademanee,et al. Hematopoietic Stem Cell Transplantation (HSCT) using Umbilical Cord Blood units (UCB) not depleted of red blood cells prior to cryopreservation , 2006 .
[14] K. Metze,et al. Late effects of chronic graft-vs.-host disease in minor salivary glands. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[15] D. Pellicci,et al. Stem cell mobilization with novel G-CSF analogues augment NKT cell restricted graft-versus-leukaemia effects , 2005 .
[16] G. Vogelsang,et al. Chronic graft versus host disease , 2004, British journal of haematology.
[17] E. Farmer,et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). , 1996, Bone marrow transplantation.
[18] H. Hönigsmann,et al. Photochemotherapy improves chronic cutaneous graft-versus-host disease. , 1990, Journal of the American Academy of Dermatology.
[19] Stephanie J. Lee. Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[20] S. Lee,et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease , 2009, Leukemia.
[21] P. Lachenbruch,et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] M. Turner,et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.